Comment Section for Companies Were Big on CBD. Not Anymore. - The New York Times

The article from The New York Times discusses the challenges facing the CBD industry due to the lack of federal regulation and differing state laws, which have made selling CBD products difficult. The piece highlights the story of Vybes, a CBD-infused drink that has struggled to find national distribution due to these regulatory issues. The CBD industry was once booming, with the compound being marketed as a beneficial health and relaxation ingredient. Various products, including water, chocolates, and skincare items, were infused with CBD, and even large corporations joined the trend. However, the industry has lost momentum in recent years, with many companies shelving their CBD plans and numerous startups closing or adjusting their growth projections. The industry's hopes of revival through federal regulation in a new farm bill were dashed when Congress extended the 2018 version. A significant problem remains public confusion over CBD, its legality, and its effects. The FDA has yet to create rules for CBD use in dietary supplements or conventional foods, saying a new regulatory pathway must be established. State regulators have also begun pulling CBD products from shelves, and companies face obstacles in selling or advertising online. The COVID-19 pandemic also impacted the industry, diverting large companies and investors' attention away from the CBD space.